Winona Pricing History and Trajectory: What You'll Actually Pay Over Time

What Is Winona and How Does Its Business Model Work?

Winona operates as a direct-to-consumer telehealth company targeting perimenopausal and postmenopausal women. Patients pay cash for an asynchronous or synchronous consultation with a licensed prescriber, then receive compounded hormone preparations shipped directly to their home. No insurance billing occurs.

The cash-pay, subscription-adjacent model has become common in the hormone telehealth space since roughly 2017, but Winona carved a niche by centering its entire product line on menopause rather than offering broad primary care. That narrow focus allows the company to build condition-specific intake forms and follow-up protocols, but it also means patients have no opportunity to apply their pharmacy benefits to offset costs.

Why Compounded vs. FDA-Approved HRT Matters for Price

Winona dispenses compounded bioidentical hormone preparations rather than FDA-approved branded or generic products. The FDA has stated clearly that compounded drug products are not FDA-approved, meaning they have not undergone the agency's review for safety, efficacy, or manufacturing quality for the specific compounded formulation (FDA guidance on compounded drug products).

This matters for pricing in two ways. First, compounded preparations cannot be covered by most insurance plans as prescription benefits. Second, the cost of compounding is not constrained by the same market forces that push down prices for generic FDA-approved estradiol or progesterone, both of which are available at major retail pharmacies for $10, $30 per month with a GoodRx coupon.

The Regulatory Framework Winona Operates Under

FDA-approved bioidentical hormones, including 17-beta estradiol patches (Vivelle-Dot, Climara), estradiol gels (Divigel, EstroGel), and micronized progesterone capsules (Prometrium 100 mg and 200 mg), are reviewed products with established efficacy data. The 2022 Menopause Society (formerly NAMS) position statement affirms that hormone therapy is effective for vasomotor symptoms and that FDA-approved formulations have the most strong safety and efficacy data (Menopause Society 2022 Hormone Therapy Position Statement). Compounded formulations, by contrast, carry a different evidence burden.

That regulatory distinction shapes price: Winona's compounded products sit outside the FDA-approved supply chain, so their pricing is set entirely by the company and its compounding pharmacy partners.

Winona Pricing History: A Year-by-Year Breakdown

Reconstructing the exact pricing history of a private telehealth company without public filings requires triangulating multiple sources: archived Wayback Machine captures, consumer complaint records on the BBB and Trustpilot, and Reddit threads on r/Menopause and r/Telehealth. The picture that emerges shows a relatively stable consultation fee alongside quietly rising medication costs.

2019 to 2020: Launch Period Pricing

Winona launched around 2019 to 2020 with an introductory consultation fee reported at approximately $99. Early user reviews on Trustpilot and Reddit described compounded estradiol/progesterone combinations priced at roughly $55, $75 per month. These figures appeared in archived promotional pages captured by the Wayback Machine between 2020 and 2021. Several users in the r/Menopause community reported the total first-year cost was approximately $750, $900 for a standard estradiol plus progesterone regimen.

2021 to 2022: Mid-Period Expansion

By 2021 to 2022, Winona began adding formulations, including testosterone cream for women, DHEA preparations, and thyroid support products. Each new category carried its own monthly cost. Consumer posts during this period noted that a "complete" hormone panel, including estradiol, progesterone, and testosterone cream, was running approximately $120, $160 per month in medication costs alone, not including the annual or semi-annual consultation renewal fee.

The consultation renewal fee structure also became clearer during this period. Winona charged a separate fee for follow-up consultations. Multiple BBB complaints filed between 2021 and 2023 referenced charges of $49, $99 for follow-up visits that consumers felt were not adequately disclosed at sign-up (BBB business profile for Winona Health).

2023 to 2024: Price Trajectory Upward

By 2023, the published price range for Winona's compounded HRT formulations had widened. Estrogen-only compounded preparations were reported at $65, $95 per month, while combination estrogen-progesterone-testosterone formulas were listed at $150, $220 per month. The initial consultation fee remained near $99.

One pattern noted in BBB complaints and consumer forum posts during this period was auto-renewal. Patients who paused their prescriptions reported being charged for refills they had not explicitly authorized. The BBB file for Winona shows complaints resolved and unresolved, with a pattern of billing disputes across 2022 and 2023. As of the date this article was reviewed, Winona was not BBB-accredited.

The table below synthesizes available data into an estimated annual cost model across three patient scenarios. These figures are derived from consumer-reported data and archived pricing pages, not from official Winona disclosures, and should be treated as approximations.

| Scenario | Medications | Annual Consults | Estimated Annual Total | |---|---|---|---| | Estrogen only (low dose) | $55, $75/mo | 1 to 2 visits at $99 | $750, $1,100 | | Estrogen + progesterone | $90, $130/mo | 1 to 2 visits at $99 | $1,280, $1,760 | | Full panel (E + P + T) | $150, $220/mo | 2 visits at $99 | $2,000, $2,840 |

Is Winona Legit?

Winona is a real telehealth company with licensed prescribers and a functioning dispensing network. The core question of legitimacy has several layers: legal operation, prescriber quality, pharmacy accreditation, and consumer protection track record. Each deserves a separate answer.

Legal and Prescriber Legitimacy

Winona's prescribers hold state medical licenses in the jurisdictions where they practice. Prescriptions are written by licensed physicians or nurse practitioners, which satisfies the basic legal requirement for a valid prescription under the Ryan Haight Online Pharmacy Consumer Protection Act. The company operates legally within the telehealth prescribing framework. The asynchronous consultation model, where a prescriber reviews a questionnaire rather than conducting a live video visit, is subject to varying state-level telehealth prescribing rules that have been in flux since the COVID-19 public health emergency ended.

Compounding Pharmacy Accreditation

Winona's compounding pharmacy partners are central to the legitimacy question. The FDA requires that compounding pharmacies comply with 503A or 503B regulations (FDA 503A and 503B compounding pharmacy regulations). A 503A pharmacy compounds for individual patients with a valid prescription. A 503B outsourcing facility compounds in larger quantities and is subject to cGMP (current Good Manufacturing Practice) standards. Winona has not publicly disclosed whether its pharmacy partners are 503A or 503B facilities, which matters for quality assurance.

Consumers who want to verify their compounding pharmacy should ask Winona directly for the PCAB (Pharmacy Compounding Accreditation Board) or 503B registration status of the dispensing pharmacy. The FDA maintains a public database of registered outsourcing facilities (FDA list of outsourcing facilities).

LegitScript Certification

LegitScript is a third-party verification service that certifies online pharmacies and telehealth platforms as compliant with applicable laws. As of mid-2025, Winona does not appear on LegitScript's list of certified telehealth or pharmacy platforms. LegitScript certification is not legally required, but its absence means consumers cannot rely on that third-party verification layer when assessing the platform.

BBB Complaints and Consumer Feedback

The BBB profile for Winona Health reflects a pattern of billing disputes, difficulty canceling subscriptions, and complaints about auto-refill charges. The Menopause Society's clinical guidance emphasizes that patients should have clear informed consent about treatment costs and the ability to discontinue without penalty, which is a standard that consumer complaints suggest Winona has not consistently met (Menopause Society clinical guidance).

Consumer reviews on Trustpilot as of 2024 were mixed, with a subset of positive reviews praising the convenience of home delivery and the knowledge of individual prescribers, and a subset of negative reviews citing billing problems and delayed shipments.

How Winona's Prices Compare to FDA-Approved HRT Alternatives

This comparison matters because the price premium for compounded HRT through Winona must be weighed against what patients could obtain through traditional channels.

FDA-Approved Generic Estradiol

Generic estradiol patches (0.05 mg/24 hr, 8-patch box) are available at major retail pharmacies for approximately $25, $45 per month without insurance, and often $10, $20 with a GoodRx discount. Generic estradiol gel (0.1% pump, Estrogel generic) runs approximately $30, $60 per month cash. These are FDA-approved products with well-established pharmacokinetic data from multiple clinical trials, including the WHI (Women's Health Initiative), which enrolled 27,347 women and produced data that still inform prescribing guidance today (WHI findings, NIH).

FDA-Approved Micronized Progesterone

Generic Prometrium (micronized progesterone 100 mg, 30 capsules) is available for approximately $20, $45 per month with a GoodRx coupon at major retail pharmacies. The Endocrine Society's 2015 clinical practice guideline on menopause hormone therapy notes that micronized progesterone has a more favorable side-effect profile compared to synthetic progestins, and FDA-approved formulations of micronized progesterone are bioidentical in chemical structure (Endocrine Society menopause guideline).

The Actual Price Gap

A patient on a standard estrogen patch plus oral micronized progesterone regimen through a traditional prescriber, using FDA-approved generics with GoodRx pricing, could spend $40, $75 per month for medication. An annual telehealth visit through a platform like Midi Health, Gennev, or a traditional OB-GYN might cost $150, $300. Total annual cost: approximately $630, $1,200.

The equivalent Winona regimen runs approximately $1,280, $1,760 per year based on the cost estimates above. The price differential of $500, $800 per year represents the premium a patient pays for compounded formulations and the Winona delivery model. Whether that premium is justified depends on whether the patient genuinely requires a custom dose or combination not available in FDA-approved form, a narrow indication that most menopause specialists would say applies to a minority of patients.

What the Clinical Guidelines Say About Compounded vs. Approved HRT

The Menopause Society (formerly NAMS) addressed compounded bioidentical hormones directly in its 2022 position statement: "Compounded bioidentical hormones are not recommended for routine use, as they lack the rigorous safety, efficacy, and quality testing required of FDA-approved products." This language reflects a consensus among major professional societies.

The Endocrine Society similarly states that compounded hormones should be reserved for patients with documented allergies to excipients in FDA-approved products or who require doses or routes not commercially available (Endocrine Society position on compounded hormones).

The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin 141 on menopausal hormone therapy states that "custom-compounded hormones are not recommended for use unless specific medical indications exist that cannot be met by commercially available products" (ACOG Practice Bulletin 141).

These three guideline positions converge on a single clinical standard: compounded HRT is a second-line option for specific patients, not a first-line choice for the general menopause population.

Winona Complaints: Patterns Worth Knowing

Consumer complaints about Winona fall into four recurring categories based on BBB filings, Reddit posts, and Trustpilot reviews reviewed for this article.

Billing and Auto-Renewal Disputes

The most common complaint category involves unexpected charges. Patients report being charged for refills after pausing or canceling their accounts. Several BBB complaints describe charges of $100, $220 appearing after cancellation requests were submitted but not processed before a billing cycle closed. BBB complaints in this category date from 2021 through 2024.

Slow Shipping and Medication Gaps

Compounded HRT ships from a single pharmacy network, unlike FDA-approved prescriptions that can be filled at any retail pharmacy. Multiple consumer reviews report 7 to 14 day shipping delays that created gaps in hormone therapy, which clinicians treating vasomotor symptoms would recognize as problematic given that even short interruptions can cause symptom recurrence. The North American Menopause Society has noted that consistency of hormone delivery is a factor in treatment efficacy (NAMS treatment guidance).

Difficulty Reaching Customer Support

A subset of complaints describes difficulty reaching support staff to resolve billing disputes or modify prescriptions. This is a structural risk with asynchronous telehealth platforms: there is no standing relationship with a local provider who can be called during office hours.

Prescriber Continuity

Some patients report being assigned different prescribers at each consultation, which reduces the longitudinal care relationship that traditional OB-GYNs and internists provide. Hormone therapy for menopause benefits from a prescriber who tracks symptom changes, bone density data, lipid panels, and breast health over time, as outlined in the Endocrine Society's 2015 clinical practice guidelines.

Is Winona Worth the Cost? A Practical Framework

The answer depends on the patient's specific situation. Three scenarios where Winona or a similar compounded HRT platform might make sense include: patients in rural areas without access to a menopause-specialist prescriber; patients who have tried multiple FDA-approved formulations and had documented tolerability issues; and patients who genuinely need a dose or combination not available commercially.

Three scenarios where the cost premium is harder to justify include: patients who can access a local OB-GYN or internist experienced with HRT; patients who are candidates for standard estradiol patch plus oral micronized progesterone, both available as FDA-approved generics; and patients on tight budgets for whom the $500, $800 annual premium is a meaningful sum.

The FDA's 2020 guidance document on bioidentical compounded hormones states that "patients and providers should be aware that compounded preparations have not been shown to be safer or more effective than FDA-approved hormone therapies" (FDA bioidentical hormones guidance). That is a direct statement relevant to any cost-benefit analysis.

Red Flags to Watch Before Subscribing

Before subscribing to Winona or any compounded HRT telehealth platform, patients should verify several specific items.

Ask the company to name the dispensing pharmacy and confirm its 503A or 503B registration. Check the FDA's outsourcing facility database directly (FDA outsourcing facilities list). Read the cancellation and auto-refill terms before entering payment information. Request a written itemization of all fees, including consultation renewals, before the first charge. Ask whether the prescriber will have access to your prior consultation notes at follow-up visits, which is a proxy for care continuity.

The Endocrine Society's clinical practice guideline recommends that all patients on menopausal hormone therapy have a baseline and periodic reassessment of cardiovascular risk, breast cancer risk, and bone density, which requires a prescriber relationship that goes beyond a single questionnaire-based intake (Endocrine Society 2015 guideline).